Cambridge, Massachusetts-based Kymera Therapeutics Inc, a biotechnology company, has closed $65 million in Series B financing. The lead investors were 6 Dimensions Capital, Bessemer Venture Partners and Pfizer Ventures.
Source: Press Release
Cambridge, Massachusetts-based Kymera Therapeutics Inc, a biotechnology company, has closed $65 million in Series B financing. The lead investors were 6 Dimensions Capital, Bessemer Venture Partners and Pfizer Ventures.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: